Importer of Controlled Substances; Notice of Registration, 56490-56491 [05-19192]
Download as PDF
<![CDATA[
56490
Federal Register / Vol. 70, No. 186 / Tuesday, September 27, 2005 / Notices
the subject of the review on or before
February 17, 2006. On March 14, 2006,
the Commission will make available to
parties all information on which they
have not had an opportunity to
comment. Parties may submit final
comments on this information on or
before March 17, 2006, but such final
comments must not contain new factual
information and must otherwise comply
with section 207.68 of the Commission’s
rules. All written submissions must
conform with the provisions of section
201.8 of the Commission’s rules; any
submissions that contain BPI must also
conform with the requirements of
sections 201.6, 207.3, and 207.7 of the
Commission’s rules. The Commission’s
rules do not authorize filing of
submissions with the Secretary by
facsimile or electronic means, except to
the extent permitted by section 201.8 of
the Commission’s rules, as amended, 67
FR 68036 (November 8, 2002). Even
where electronic filing of a document is
permitted, certain documents must also
be filed in paper form, as specified in II
(C) of the Commission’s Handbook on
Electronic Filing Procedures, 67 FR
68168, 68173 (November 8, 2002).
Additional written submissions to the
Commission, including requests
pursuant to section 201.12 of the
Commission’s rules, shall not be
accepted unless good cause is shown for
accepting such submissions, or unless
the submission is pursuant to a specific
request by a Commissioner or
Commission staff.
In accordance with sections 201.16(c)
and 207.3 of the Commission’s rules,
each document filed by a party to the
review must be served on all other
parties to the review (as identified by
either the public or BPI service list), and
a certificate of service must be timely
filed. The Secretary will not accept a
document for filing without a certificate
of service.
Authority: This review is being conducted
under authority of title VII of the Tariff Act
of 1930; this notice is published pursuant to
section 207.62 of the Commission’s rules.
By order of the Commission.
Issued: September 22, 2005.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05–19287 Filed 9–26–05; 8:45 am]
BILLING CODE 7020–02–P
VerDate Aug<31>2005
14:52 Sep 26, 2005
Jkt 205001
DEPARTMENT OF JUSTICE
Notice of Lodging of Settlement
Agreement Pursuant to the
Comprehensive Environmental
Response Compensation and Liability
Act (‘‘CERCLA’’)
Notice is hereby given that on
September 20, 2005, a proposed
Settlement Agreement in In re Huffy
Corp., No. 04–39148 through 04–39167,
was lodged with the United States
Bankruptcy Court for the Southern
District of Ohio.
On March 14, 2005, the United States,
on behalf of the Environmental
Protection Agency (‘‘EPA’’), filed a Proof
of Claim under Section 107(a) of the
Comprehensive Environmental
Response, Compensation, and Recovery
Act, as amended (‘‘CERCLA’’), 42 U.S.C.
9607(a), against Debtor Huffy
Corporation seeking recovery of $20.6
million in unrecovered costs previously
incurred, plus interest, and estimated
future oversight costs of $2 million at
the Baldwin Park Operable Unit
(‘‘BPOU’’) of the San Gabriel Superfund
Site located in Los Angeles County,
California for remedy that will cost
approximately $200 million. EPA’s
Proof of Claim also seeks $2.1 million in
unrecovered costs previously incurred,
plus interest, and estimated future costs
of $8 million at the Lammers Barrel
Superfund Site in Beavercreek, Ohio.
The Settlement Agreement provides that
the United States will have an allowed
general unsecured claim against the
Debtor in the amount of $1,050,000 for
both sites, and that Huffy Corporation
will pay the United States $246,000 to
resolve the allowed claim from the
proceeds of certain insurance
settlements. The Settlement will be
contingent upon Court approval of the
insurance settlements.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the Consent Decree.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611, and should refer to In re
Huffy Corp., Nos. 04–39148–39167, D.J.
Ref. 90–11–3–07706/1.
The Consent Decree may be examined
at the Office of the United States
Attorney, Southern District of Ohio,
Western Division, 200 W. Second Street,
Room 602, Dayton, Ohio 45402 (contact
Assistant United States Attorney Dale
Ann Goldberg), at U.S. EPA Region V,
77 West Jackson Blvd., Chicago, IL
60604 (contact Assistant Regional Maria
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Gonzalez), and U.S. EPA Region IX, 75
Hawthorne St., San Francisco, CA 94105
(contact Senior Attorney Lewis
Maldonado, Office of Regional Counsel).
During the public comment period, the
Consent Decree, may also be examined
on the following Department of Justice
Web site: https://www.usdoj.gov/enrd/
open.html. A copy of the Consent
Decree may also be obtained by mail
from the Consent Decree Library, P.O.
Box 7611, U.S. Department of Justice,
Washington, DC 20044–7611 or by
faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy form the Consent
Decree Library, please enclose a check
in the amount of $8.25 (25 cents per
page reproduction cost) payable to the
U.S. Treasury.
William D. Brighton,
Assistant Chief, Environmental, Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. 05–19170 Filed 9–26–05; 8:45am]
BILLING CODE 4410–15–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated March 29, 2005 and
published in the Federal Register on
April 6, 2005, (70 FR 17473–17474),
Sigma Aldrich Corporation, 3500 Dekalb
Street, St. Louis, Missouri 63118, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
Schedules I and II:
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Mescaline (7381) ..........................
4-Bromo-2,5-dimethoxy-amphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
E:\FR\FM\27SEN1.SGM
27SEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
Federal Register / Vol. 70, No. 186 / Tuesday, September 27, 2005 / Notices
Drug
Schedule
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Psilocyn (7438) .............................
Benzylpiperazine (BZP) (7493) ....
Heroin (9200) ...............................
Normorphine (9313) .....................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Diprenorphine (9058) ...................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium powdered (9639) ..............
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Dated: September 20, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–19192 Filed 9–26–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Office of the Secretary
Submission for OMB Review:
Comment Request
September 21, 2005.
II
II
II
II
II
The company plans to import the
listed controlled substances for drug
testing and analysis.
Following the Notice of Application
publication on April 6, 2005, (70 FR
17473–17474), Sigma Aldrich
Corporation, 3500 Dekalb Street, St.
Louis, Missouri 63118, requested a
company name change to Sigma Aldrich
Manufacturing LLC. DEA conducted a
full investigation and inspection of the
company which was found to be in
compliance with all required
regulations.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Sigma Aldrich Corporation to import
the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Sigma Aldrich Corporation
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
VerDate Aug<31>2005
14:52 Sep 26, 2005
Jkt 205001
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
Sections 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the
above named company is granted
registration as an importer of the basic
classes of controlled substances listed.
The Department of Labor (DOL) has
submitted the following public
information collection request (ICR) to
the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (Pub. L. 104–13,
44 U.S.C. Chapter 35). A copy of this
ICR, with applicable supporting
documentation, may be obtained by
calling the Department of Labor. To
obtain documentation contact Ira Mills
on 202–693–4122 (this is not a toll-free
number) or e-mail: Mills.Ira@dol.gov.
Comments should be sent to Office of
Information and Regulatory Affairs,
Attn: OMB Desk Officer for ETA, Office
of Management and Budget, Room
10235, Washington, DC 20503, 202–
395–7316 (this is not a toll free number),
within 30 days from the date of this
publication in the Federal Register.
The OMB is particularly interested in
comments which:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
56491
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Agency: Employment and Training
Administration (ETA).
Type of Review: Regular extension of
a currently approved collection.
Title: Labor Condition Application for
H–1B, H–1B1, and E–3 Nonimmigrants.
OMB Number: 1205–0310.
Frequency: On occasion.
Affected Public: Business or other forprofit, individuals or households, notfor-profit institutions, Federal
government, and state, local, or tribal
governments.
Type of Response: Recordkeeping;
reporting.
Number of Respondents: 200,000.
Annual Responses: 325,200.
Average Response time: 45 minutes or
less, depending on the form.
Total Annual Burden Hours: 279,170.
Total Annualized Capital/Startup
Costs: 0.
Total Annual Costs (operating/
maintaining systems or purchasing
services): 0.
Description: The application form and
other requirements in these regulations
for employers seeking to use
nonimmigrants (H–1B, H–1B1, and E–3)
in specialty occupations and as fashion
models will permit the Department to
meet its statutory responsibilities for
program administration, management,
and oversight.
Ira L. Mills,
Departmental Clearance Officer.
[FR Doc. 05–19249 Filed 9–26–05; 8:45 am]
BILLING CODE 4510–30–P
DEPARTMENT OF LABOR
Employment and Training
Administration
[TA–W–57,661]
B&K Acquisition Corporation, Inc.,
Murrysville, PA; Notice of Termination
of Investigation
Pursuant to Section 221 of the Trade
Act of 1974, as amended, an
investigation was initiated on August 3,
2005, in response to a worker petition
filed by the company on behalf of
workers at B&K Acquisition
Corporation, Inc., Murrysville,
Pennsylvania.
The petitioner has requested that the
petition be withdrawn. Consequently,
the investigation has been terminated.
E:\FR\FM\27SEN1.SGM
27SEN1
]]>Agencies
[Federal Register Volume 70, Number 186 (Tuesday, September 27, 2005)]
[Notices]
[Pages 56490-56491]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-19192]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 29, 2005 and published in the Federal
Register on April 6, 2005, (70 FR 17473-17474), Sigma Aldrich
Corporation, 3500 Dekalb Street, St. Louis, Missouri 63118, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as an importer of the basic classes of controlled
substances listed in Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
Aminorex (1585)............................ I
Gamma Hydroxybutyric Acid (2010)........... I
Methaqualone (2565)........................ I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Mescaline (7381)........................... I
4-Bromo-2,5-dimethoxy-amphetamine (7391)... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
[[Page 56491]]
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (MDMA) I
(7405).
4-Methoxyamphetamine (7411)................ I
Bufotenine (7433).......................... I
Psilocyn (7438)............................ I
Benzylpiperazine (BZP) (7493).............. I
Heroin (9200).............................. I
Normorphine (9313)......................... I
Etonitazene (9624)......................... I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Methylphenidate (1724)..................... II
Amobarbital (2125)......................... II
Pentobarbital (2270)....................... II
Secobarbital (2315)........................ II
Glutethimide (2550)........................ II
Phencyclidine (7471)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Diprenorphine (9058)....................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levorphanol (9220)......................... II
Meperidine (9230).......................... II
Methadone (9250)........................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Thebaine (9333)............................ II
Opium powdered (9639)...................... II
Oxymorphone (9652)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
drug testing and analysis.
Following the Notice of Application publication on April 6, 2005,
(70 FR 17473-17474), Sigma Aldrich Corporation, 3500 Dekalb Street, St.
Louis, Missouri 63118, requested a company name change to Sigma Aldrich
Manufacturing LLC. DEA conducted a full investigation and inspection of
the company which was found to be in compliance with all required
regulations.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Sigma Aldrich Corporation to import the basic classes
of controlled substances is consistent with the public interest and
with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this time. DEA
has investigated Sigma Aldrich Corporation to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. Sections 952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named company is granted registration as
an importer of the basic classes of controlled substances listed.
Dated: September 20, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. 05-19192 Filed 9-26-05; 8:45 am]
BILLING CODE 4410-09-P
